Navigation Links
Warfarin’s Anti-clotting Property May Cause Hemorrhagic Stroke

Warfarin, an anti-clotting drug given to patients suffering from atrial fibrillation has proved effective //by reducing the number of strokes due to clotting.

However, its anti-clotting property has led to an increase in the number of strokes caused by bleeding to the brain particularly in patients over the age of 80, according to a new study.

Warfarin was earlier used as rat poison, after research in the nineties suggested Warfarin reduced the risk of ischemic stroke it became a standard treatment for people suffering from atrial fibrillation.

Matthew Flaherty, the lead researcher and a neurologist at the University of Cincinnati in Ohio, said the study results don’t necessarily mean that use of warfarin should be given up, but motivate physicians to make sure that the drug is being used appropriately.

"Doctors can use these findings to make sure they are weighing the risks and benefits of warfarin use for their patients," he said.

“The benefits of anti-clotting drugs are "undeniable" for some patients, such as those who have had blood clots,” Dr. Flaherty said.

The researcher said more research was needed to find anti-coagulants safer than warfarin to help patients who suffer from hemorrhagic strokes.

All cases of intracerebral hemorrhage (bleeding inside the brain) in the Cincinnati area between 1988 and 1999 were examined by the study. The cases connected with the use of blood-thinning drugs soared to 4.4 cases per 100,000 people by 1999 from 0.8 cases per 100,000 in 1988. In comparison, the rate of hemorrhagic strokes associated to warfarin use, rose to 45.9 per 100,000 in 1999 from 2.5 per 100,000 in 1988.

The study notes that, between 1993 and 1999, the rate of ischemic stroke in patients suffering from atrial fibrillation remained fixed at about 22 per 100,000. But previous research has shown that warfarin use has halved the rate of ischemic stroke in pat ients with atrial fibrillation.

Warfarin is known by its brand name Coumadin, which is a product of Bristol Myers Squibb.

Warfarin is used to prevent clotting in the deep-seated veins of the lower leg (deep vein thrombosis), and also to prevent pulmonary embolism in patients having chronic obstructive pulmonary disorder (COPD).


PI
'"/>




Related medicine news :

1. Aspirin surpasses Modern Anti-clotting Drugs
2. Fruits And Vegetables Have Arthritis Risk Reducing Property
3. Cancer-causing Property Of Teflon Leaves US Regulators Concerned
4. Opposition against Amendments in the Intellectual Property Law
5. Is Diabetes the Leading Cause of Kidney Failure in India
6. Antibiotics Dangerous for Diarrhoea in Children Caused by E.Coli
7. Paracetamol May Cause Live Damage Warns Consumer Education and Research Centre
8. Breast Cancer Surgery Causes Psychological problems
9. Arthritis Drug May Cause Liver Damage
10. Causes of weakness in the aged
11. Gene Mutation Causes Ovarian Failure
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/18/2017)... ... August 18, 2017 , ... August 18, 2017 — Mediaplanet ... for active, healthy lifestyles and highlighting the importance of proactive eye and ear ... and shares the latest innovations in hearing aid technology. , According to ...
(Date:8/18/2017)... ... August 18, 2017 , ... The Dawn Johnson Insurance Group, a ... charity drive to generate community support for efforts to educate the local population on ... for all types of cancer. , Each day in America, roughly 4,600 new ...
(Date:8/18/2017)... TX (PRWEB) , ... August 18, 2017 , ... ... assistance and financial planning services to communities in east Texas, is launching a ... Brain Tumor Foundation. , Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... planning firm that serves residential and commercial clients in the greater Houston region, ... raise community support for the fight against cancer. , Founded by Tony and ...
(Date:8/18/2017)... Raton, Fl (PRWEB) , ... August 18, 2017 ... ... largest network of highly trained practitioners specializing in bioidentical hormone replacement therapy and ... associated with hormone imbalance and conditions of aging, such as menopause, andropause, thyroid ...
Breaking Medicine News(10 mins):
(Date:8/10/2017)... , Aug. 10, 2017  Physical Rehabilitation Network (PRN), ... in Lakewood, Colorado . The reputable clinic ... Lipkin , PT, DPT with his staff of four clinicians. ... of Pittsburgh and brings over 10 years of experience with ... Belmar PT marks the 10th PRN clinic in and ...
(Date:8/7/2017)... GAITHERSBURG, Md. , Aug. 7, 2017 /PRNewswire/ ... for healthcare member acquisition, retention, and engagement, announced ... Director of Strategy and Product Development, effective as ... strategic consulting and technology implementation strategy for our ... years of experience in consulting and business analytics ...
(Date:8/7/2017)... Mich., Aug. 7, 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO), ... the quarter ended June 30, 2017.  All comparisons, unless otherwise ... Second Quarter 2017 Highlights ... to $1,089 million, an increase of 3.5% ... Gross margin of 7.5% versus 7.6% ...
Breaking Medicine Technology: